首页> 外文期刊>Mechanisms of Ageing and Development >Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
【24h】

Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.

机译:编码Nrf2的NFE2L2单倍型影响疾病进展,但不影响阿尔茨海默氏病和年龄相关性白内障的风险。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Alzheimer's disease (AD) and age-related cataract, disorders characterized by protein aggregation causing late-onset disease, both involve oxidative stress. We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract. This case-control study combines an AD material (725 cases and 845 controls), and a cataract material (489 cases and 182 controls). Genetic variation in NFE2L2 and KEAP1 was tagged by eight and three tag single nucleotide polymorphisms (SNPs), respectively. Single SNPs and haplotypes were analyzed for associations with disease risk, age parameters, MMSE and AD cerebrospinal fluid biomarkers. NFE2L2 and KEAP1 were not associated with risk of AD or cataract. However, one haplotype allele of NFE2L2 was associated with 2 years earlier age at AD onset (p(c)=0.013) and 4 years earlier age at surgery for posterior subcapsular cataract (p(c)=0.019). Another haplotype of NFE2L2 was associated with 4 years later age at surgery for cortical cataract (p(c)=0.009). Our findings do not support NFE2L2 or KEAP1 as susceptibility genes for AD or cataract. However, common variants of the NFE2L2 gene may affect disease progression, potentially altering clinically recognized disease onset.
机译:阿尔茨海默氏病(AD)和年龄相关性白内障(以蛋白质聚集为特征的疾病引起迟发性疾病)均涉及氧化应激。我们假设NFE2L2和KEAP1的常见变异体,即编码Nrf2系统主要调节因子的基因,Nrf2系统是抗氧化应激的重要防御系统,可能会影响AD和/或年龄相关性白内障的风险。该病例对照研究结合了AD材料(725例和845对照)和白内障材料(489例和182对照)。 NFE2L2和KEAP1的遗传变异分别由8个和3个标记单核苷酸多态性(SNP)标记。分析了单个SNP和单倍型与疾病风险,年龄参数,MMSE和AD脑脊液生物标志物的相关性。 NFE2L2和KEAP1与AD或白内障的风险无关。然而,NFE2L2的一个单倍型等位基因与AD发病后2岁时较早年龄(p(c)= 0.013)和后囊性白内障手术时较早年龄4岁(p(c)= 0.019)相关。 NFE2L2的另一种单倍型与皮质白内障手术后4岁以后相关(p(c)= 0.009)。我们的发现不支持NFE2L2或KEAP1作为AD或白内障的易感基因。但是,NFE2L2基因的常见变异可能会影响疾病进展,从而可能改变临床上公认的疾病发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号